Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rising-VTE study of venous thromboembolism in lung cancer and edoxaban treatment
jRCTs061180025Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of edoxaban in venous thromboembolism (VTE) (3 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Symptomatic VTE incidence rate in observation group and VTE relapse rate after edoxaban. Started Jun 2016; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on jRCTs061180025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180025.